COMBO oropharyngeal airway during sedated ERCP
Official title: COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
Run by Zhejiang University · NCT07012772 · Data updated 2026-11-12
This test will see if the COMBO Endoscopy Oropharyngeal Airway reduces episodes of low oxygen (hypoxia) in adults undergoing ERCP with propofol sedation.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 2 sites (Hangzhou, Zhejiang and 1 other locations) |
| Status | Recruiting |
| Started | June 12, 2025 |
| Main results expected | September 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT07012772 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 or older with ASA physical status I–III who are scheduled for ERCP under propofol sedation for procedures expected to last 45 minutes or less and who can give informed consent.
✕Probably not a fit
Patients with COPD or other chronic pulmonary disease requiring oxygen, severe cardiac or renal failure, coagulopathy, active upper respiratory infection, pregnancy, or anatomical issues preventing airway insertion are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2 interventional trial enrolls adults (ASA I–III) scheduled for ERCP under propofol sedation and uses the COMBO Endoscopy Oropharyngeal Airway, a device combining capnography, a bite block, oxygen delivery, and an oropharyngeal airway, during the procedure. The main outcome is the incidence of hypoxia during procedures expected to last 45 minutes or less. Key exclusions include significant pulmonary disease, severe cardiac or renal dysfunction, coagulopathy, active upper airway infection, pregnancy, and airway anatomy that prevents device use. The study is conducted at the First Affiliated Hospital, Zhejiang University School of Medicine in Hangzhou, China.
Why it matters
Potential benefit: If successful, the device could lower the risk of low-oxygen events during sedated ERCP and improve patient safety.
How similar studies have gone: Elements such as capnography monitoring and airway adjuncts have reduced respiratory events during procedural sedation, but the COMBO integrated airway device is relatively new and has limited published trial data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years; * The ASA classification ranges from I to III. * Patients have signed the informed consent form. * Patients scheduled to undergo sedated ERCP examination; * The estimated duration of the procedure does not exceed 45 minutes. Exclusion Criteria: 1. Patients with coagulation disorders, tendency for oral/nasal bleeding, mucosal injury/occupying lesions, or difficult oropharyngeal airway insertion making airway management unfeasible; 2. Severe cardiac dysfunction (\<4 METs); 3. Severe renal insufficiency (requiring preoperative dialysis); 4. Child-Pugh class C; 5. Diagnosed chronic obstructive pulmonary disease (COPD) or other acute/chronic pulmonary diseases requiring long-term/intermittent oxygen therapy; 6. Increased intracranial pressure; 7. Upper respiratory tract infections (oral/nasal/pharyngeal); 8. Fever (core temperature \>37.5°C); 9. Confirmed pregnancy or current breastfeeding; 10. Allergy to sedatives (e.g., propofol) or medical adhesives; 11. Emergency procedures; 12. Multiple trauma injuries; 13. Peripheral oxygen saturation (SpO2) levels below 95% while breathing room air preoperatively; 14. BMI \<18.5 or \>30 kg/m²; 15. Current participation in other clinical trials; 16. Other conditions deemed ineligible by investigators.
Where it's running
-
he First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting -
The First Affiliated Hospital,Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: DiSan Head of Anesthesiology, PhD
- Email: 184872238@qq.com
- Phone: 86+18616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Supraglottic oxygen delivery through an endotracheal tube for ERCP under deep sedation
This tests whether delivering oxygen just above the vocal cords through an endotracheal tube can prevent low oxygen levels in adults having ERCP with deep sedation.
-
Electrosurgical Patterns and Learning Curve in Laparoscopic Gallbladder Surgery
This study observes how surgeon experience relates to patterns of electrosurgery use during elective laparoscopic gallbladder removal to see if experience affects intraoperative difficulty.
-
Improvised retrieval bag vs direct gallbladder extraction in laparoscopic cholecystectomy
This trial tests whether using an improvised retrieval bag to remove the gallbladder during laparoscopic cholecystectomy is as safe and effective as removing it directly without a bag in adults with gallbladder stones.
-
Short-stay aggressive hydration to prevent post-ERCP pancreatitis
This trial tests whether a short, high-volume IV hydration with Lactated Ringer's plus a rectal indomethacin can prevent post-ERCP pancreatitis in adults undergoing ERCP.
-
Time to Lose Consciousness With Remimazolam vs Propofol for Anesthetic Induction
This study tests whether remimazolam changes the time to loss of consciousness compared with propofol for anesthesia induction in adults undergoing elective laparoscopic gallbladder removal.
-
Phosphate therapy for adults with acute pancreatitis
This study tests whether giving phosphate through an IV can help adults with acute pancreatitis treated in the emergency department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.